![Christopher Degnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 87 187 $ in data 31/07/2026
Christopher Degnan currently works at UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2024.
Mr. Degnan also formerly worked at AstraZeneca PLC, as Senior Finance Director from 2004 to 2014, Endo International Plc, as Chief Financial Officer from 2016 to 2018, Endo Pharmaceuticals, Inc., as Chief Financial Officer & Vice President-Finance, Verrica Pharmaceuticals, Inc., as Chief Financial & Accounting Officer from 2018 to 2019, and Galera Therapeutics, Inc., as Chief Financial & Accounting Officer.
Mr. Degnan received his undergraduate degree from the University of Notre Dame.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/01/2026 | 2.280 ( 0% ) | 87 187 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| UROGEN PHARMA LTD. | Direttore Finanziario/CFO | 08/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
| GALERA T COM USD0. | Direttore Finanziario/CFO | 31/08/2024 |
| VERRICA PHARMACEUTICALS INC. | Direttore Finanziario/CFO | 07/10/2019 |
| ENDO INTERNATIONAL PLC | Direttore Finanziario/CFO | 01/03/2018 |
| ASTRAZENECA PLC | Direttore Finanziario/CFO | 01/11/2014 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
